Evidence map›Paper›PMID 39383530›Full record

ArticleOnline journal of public health informatics2024

Facilitators, Barriers, and Potential Impacts of Implementation of e-Pharmacy in India and its Potential Impact on Cost, Quality, and Access to Medicines: Scoping Review.

Aditi Apte, Heber Rew Bright, Sandeep Kadam, Thambu David Sundarsanam, Sujith J Chandy

Abstract readScoping Review
In one paragraph

Article in Online journal of public health informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aditi ApteKEM Hospital Research Centre, Pune, India.ORCID https://orcid.org/0000-0002-9120-2569
Heber Rew BrightDepartment of Pharmacy, Christian Medical College, Vellore, India.ORCID https://orcid.org/0000-0002-3149-5750
Sandeep KadamDepartment of Pediatrics and Neonatology, KEM Hospital, Pune, India.ORCID https://orcid.org/0000-0002-3238-1368
Thambu David SundarsanamDepartment of Medicine, Christian Medical College, Vellore, India.ORCID https://orcid.org/0000-0001-7283-7836
Sujith J ChandyDepartment of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, India.ORCID https://orcid.org/0000-0001-9167-3750

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgrounde-Pharmacy can potentially solve problems related to the quality of services and products, cost, and access to medicines in low- and middle-income countries. This review aims to understand the facilitators and barriers to the implementation of e-pharmacy in India.

objectiveThis scoping review aimed (1) to understand the facilitators and barriers to the use of e-pharmacy in India and (2) to estimate the potential for e-pharmacy in India for improving access to medication, improving the quality of services and medicines, and decreasing costs of medications.

methodsAll published and gray literature from July 1, 2011, to June 30, 2021, relating to e-pharmacy, was searched from MEDLINE, Scopus, ProQuest, and Google using a systematic search strategy.

resultsIn total, 1464 titles and abstracts were screened, of which 47 full-texts were included in the review. e-Pharmacy can potentially improve access to medications for remote areas, and old and debilitated individuals. e-Pharmacies can enable lean supply chain management, lower cost, and allow easy tracking of dispensed medicines. There is potential for integration of e-pharmacy services into the national program of Bhartiya Jan Aushadhi Pariyojana. However, the country is not adequately regulated to prevent the growth of illicit e-pharmacies. Lack of global accreditation and internet coverage, digital literacy, and transnational access are other challenges.

conclusionsE-pharmacy has the potential to improve universal health coverage in India by improving access to medicines and lowering the overall cost of health care. However, future growth will need specific regulations and accreditation mechanisms.

trial registrationOpen Science Forum; https://doi.org/10.17605/OSF.IO/6R9YQ.

Indexed as

drug prescribingePharmacyinternet pharmacymedicationsonline pharmacyprescribing systemsprescriptionstelepharmacy

Identifiers

PMID39383530
PMCPMC11499724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.